Published in Int J Dev Biol on January 01, 2005
Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol Cancer Res (2008) 1.99
The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? Br J Pharmacol (2007) 1.38
Role of the endothelin axis and its antagonists in the treatment of cancer. Br J Pharmacol (2011) 1.21
Malignant melanoma in the 21st century: the emerging molecular landscape. Mayo Clin Proc (2008) 1.13
The role of positive selection in determining the molecular cause of species differences in disease. BMC Evol Biol (2008) 1.11
Endothelin B receptor, a new target in cancer immune therapy. Clin Cancer Res (2009) 1.05
Melanocyte receptors: clinical implications and therapeutic relevance. Dermatol Clin (2007) 1.01
Form-deprivation myopia in chick induces limited changes in retinal gene expression. Invest Ophthalmol Vis Sci (2007) 1.00
Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells. PLoS One (2010) 0.98
G-protein-coupled receptors and melanoma. Pigment Cell Melanoma Res (2008) 0.97
Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma. J Invest Dermatol (2010) 0.95
Endothelin (ET)-1 and ET-3 promote expression of c-fos and c-jun in human choriocarcinoma via ET(B) receptor-mediated G(i)- and G(q)-pathways and MAP kinase activation. Br J Pharmacol (2008) 0.89
Long-lasting molecular changes in human skin after repetitive in situ UV irradiation. J Invest Dermatol (2008) 0.87
Microenvironment-derived factors driving metastatic plasticity in melanoma. Nat Commun (2017) 0.81
Zebrafish endzone regulates neural crest-derived chromatophore differentiation and morphology. PLoS One (2008) 0.75
Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration. MAbs (2016) 0.75
Substance P stimulates endothelin 1 secretion via endothelin-converting enzyme 1 and promotes melanogenesis in human melanocytes. J Invest Dermatol (2014) 0.75
Endothelin-1 (ET-1) induces resistance to bortezomib in human multiple myeloma cells via a pathway involving the ETB receptor and upregulation of proteasomal activity. J Cancer Res Clin Oncol (2016) 0.75